Related Experiment Video
Updated: May 7, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Metabolic alteration in tumorigenesis.
Hui Yang1, Yue Xiong, KunLiang Guan
1Molecular and Cell Biology Lab, Institutes of Biomedical Sciences, Shanghai Medical College; School of Life Sciences, Fudan University, Shanghai, 200032, China.
Cancer metabolism, or the Warburg Effect, has been known for decades but poorly understood. Recent genetic studies reveal that cancer-linked metabolic enzyme mutations cause metabolite buildup, altering epigenetic control in tumors.
Area of Science:
- Biochemistry
- Oncology
- Epigenetics
Background:
- The Warburg Effect, describing altered cancer cell metabolism, was identified by Otto Warburg over a century ago.
- Despite its use in tumor detection, the mechanistic understanding of cancer metabolism has lagged for decades.
- Recent genetic discoveries link human cancers to mutations in metabolic enzymes.
Purpose of the Study:
- To elucidate the mechanistic link between metabolic enzyme mutations and cancer development.
- To explore the role of metabolite accumulation in epigenetic alterations within cancer cells.
Main Methods:
- Analysis of genetic studies identifying mutations in enzymes of intermediate metabolism in human cancers.
- Investigating the downstream effects of metabolite accumulation resulting from these mutations.
Main Results:
- Mutations in various metabolic enzymes are frequently identified in human cancers.
- A common mechanism involves the accumulation of specific metabolites due to these mutations.
- These accumulated metabolites are shown to directly impact epigenetic regulatory mechanisms.
Conclusions:
- Metabolite accumulation resulting from enzyme mutations is a key mechanism in cancer.
- This accumulation influences epigenetic control, offering new avenues for understanding cancer progression.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
28:15Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Mutagenicity and Carcinogenicity
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...